Overall AIFF gets a fundamental rating of 1 out of 10. We evaluated AIFF against 34 industry peers in the Health Care Technology industry. AIFF scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AIFF has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year AIFF has reported negative net income.
In the past year AIFF has reported a negative cash flow from operations.
In the past 5 years AIFF reported 4 times negative net income.
In the past 5 years AIFF reported 4 times negative operating cash flow.

1.2 Ratios

AIFF has a worse Return On Assets (-210.50%) than 94.12% of its industry peers.
AIFF has a Return On Equity of -261.49%. This is in the lower half of the industry: AIFF underperforms 76.47% of its industry peers.

		Industry Rank	Sector Rank
ROA	-210.5%
ROE	-261.49%
ROIC	N/A

ROA(3y)-161.58%

ROA(5y)-95.74%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

AIFF does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AIFF does not have a ROIC to compare to the WACC, probably because it is not profitable.
AIFF has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AIFF has more shares outstanding
AIFF has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -11.82, we must say that AIFF is in the distress zone and has some risk of bankruptcy.
AIFF's Altman-Z score of -11.82 is on the low side compared to the rest of the industry. AIFF is outperformed by 88.24% of its industry peers.
AIFF has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-11.82

ROIC/WACCN/A

WACC9.27%

2.3 Liquidity

AIFF has a Current Ratio of 2.00. This is a normal value and indicates that AIFF is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.00, AIFF is in line with its industry, outperforming 47.06% of the companies in the same industry.
A Quick Ratio of 1.97 indicates that AIFF should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.97, AIFF is in line with its industry, outperforming 47.06% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2
Quick Ratio	1.97

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for AIFF have decreased by -4.34% in the last year.
Looking at the last year, AIFF shows a very negative growth in Revenue. The Revenue has decreased by -79.40% in the last year.
Measured over the past years, AIFF shows a very negative growth in Revenue. The Revenue has been decreasing by -59.70% on average per year.

EPS 1Y (TTM)-4.34%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%67.21%

Revenue 1Y (TTM)-79.4%

Revenue growth 3Y-80.7%

Revenue growth 5Y-59.7%

Sales Q2Q%1075.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.